The minister's reference to the US and broader international pressures belies the reality that the situation currently confronting MS patients relates to the demanded price reduction triggered by Australia's domestic policies.
Minister recommits to keeping MS medicines on the PBS while awaiting formal advice
July 15, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
How education exposes the moral and ethical limits of our health decision-making
August 11, 2026 - - Latest News -
Percheron turns to former Arovella chief Michael Baker for next phase of HMBD 002 development
August 10, 2026 - - Latest News -
Australian company points to encouraging survival signal in mesothelioma CAR-T study
August 10, 2026 - - Australian Biotech -
GBMA White Paper calls for reforms to strengthen supply chain resilience
August 10, 2026 - - Latest News -
Achieving value is meaningless if it undermines access to medicines
August 10, 2026 - - Latest News -
New Zealand's ACT announces plan for pharmacies to do a lot more, but also ownership and location reform
August 10, 2026 - - Latest News -
France the first to provide comprehensive reimbursement for GLP-1s for weight loss while Australia looks on
August 10, 2026 - - Latest News

